- News & Features
Copayment Assistance programs, such as copay cards or “discount cards”, are offered by drug manufacturers (the companies that make your drugs) to lower the high costs charged by insurance companies for non-preferred drugs.
The CreakyJoints Patient Charter can help you be proactive and get the most out of your doctor appointments.
FDA is investigating serious adverse events involving Limbrel, a product in capsule form currently being marketed as a medical food to manage the metabolic processes associated with osteoarthritis.
Adults with hypertension can lower their blood pressure by consuming less sodium and sticking to the Dietary Approaches to Stop...
More than half of cardiovascular disease patients are being denied access to a new treatment.
New research shows that rheumatoid arthritis patients benefit from participating in personalized, digital health coaching.
Arthritis patients can lower their medical costs and decrease delays by using a new online consultation tool, Chinese researchers reported at the 2017 American College of Rheumatology annual meeting in San Diego.
Osteoarthritis patients, compared to the general public, experience depressive symptoms at a rate of 20 percent, writes journalist Carina Stanton in the newsmagazine The Rheumatologist.
Rheumatoid arthritis patients who take opioids or antidepressants are likelier to fracture their bones, according to research presented at the 2017 American College of Rheumatology annual meeting in San Diego.
“The results of this preliminary study may help rheumatologists to differentiate RA patients who would successfully down-titrate biologics”
Treat-to-target, evidence-based guidelines recommend that rheumatoid arthritis patients be monitored regularly for disease activity and that therapy is adjusted —...
Women who have lupus and who are obese tend to report worse outcomes when it comes to disease activity, depression, pain, and fatigue.
New Research: Lupus patients who consume more omega-3 fatty acids tend to sleep better and to experience decreased depressive symptoms.
Study finds that most RA, PsA, and AS patients can switch from infliximab (Remicade) to biosimilar CT-P13 without losing safety or effectiveness.
Tips and solutions for common problems patients face with their healthcare providers.
Amid political arguments on both sides of the aisle, three recent studies draw upon data, rather than ideology, to suggest a tie between lack of coverage and negative health results.
Socialized medicine, a term which appears to be on the rise of late in Google searches, has been garnering headlines. Learn the difference between socialized medicine and universal healthcare.
Eating more fish — rather than fish oil supplements — might be associated with lower rheumatoid arthritis disease activity.
A new study published in the Journal of the American Heart Association questions the impact energy drinks have on users’ hearts when compared to other drinks with similar amounts of caffeine.
New research discourages thinking of individual foods in isolation and indicates that a diet combining the healthy foods can be more protective against RA than the sum of its parts.
The U.S. Food and Drug Administration is currently reviewing Simponi, an intravenous TNF-inhibitor, for psoriatic arthritis and ankylosing spondylitis patients.
Postmenopausal women with osteoporosis who took romosozumab for a year experienced “rapid and large reductions" in risk of fracturing vertebrae.
EULAR report highlights the importance of early intervention in the treatment of people with rheumatic and musculoskeletal diseases.